Literature DB >> 10517915

Renal distal tubular handling of sodium in central fluid volume homoeostasis in preascitic cirrhosis.

G Sansoè1, A Ferrari, E Baraldi, C N Castellana, M C De Santis, F Manenti.   

Abstract

BACKGROUND/AIMS: Patients with preascitic liver cirrhosis have an increased central plasma volume, and, for any given plasma aldosterone concentration, they excrete less sodium than healthy controls. A detailed study of the distribution of sodium reabsorption along the segments of the renal tubule, especially the distal one, is still lacking in preascitic cirrhosis.
METHODS: Twelve patients with Child-Pugh class A cirrhosis and nine control subjects (both groups on a normosodic diet) were submitted to the following investigations: (a) plasma levels of active renin and aldosterone; (b) four hour renal clearance of lithium (an index of fluid delivery to the loop of Henle), creatinine, sodium, and potassium; (c) dopaminergic activity, as measured by incremental aldosterone response to intravenous metoclopramide.
RESULTS: Metoclopramide induced higher incremental aldosterone responses, indicating increased dopaminergic activity in patients than controls, which is evidence of an increased central plasma volume (+30 min: 160.2 (68.8) v 83.6 (35.2) pg/ml, p<0.01; +60 min: 140.5 (80.3) v 36. 8 (36.1) pg/ml, p<0.01). Patients had increased distal fractional sodium reabsorption compared with controls (26.9 (6.7)% v 12.5 (3. 4)% of the filtered sodium load, p<0.05). In the patient group there was an inverse correlation between: (a) absolute distal sodium reabsorption and active renin (r -0.59, p<0.05); (b) fractional distal sodium reabsorption and sodium excretion (r -0.66, p<0.03).
CONCLUSIONS: These data suggest that in preascitic cirrhosis the distal fractional tubular reabsorption of sodium is increased and critical in regulating both central fluid volume and sodium excretion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10517915      PMCID: PMC1727721          DOI: 10.1136/gut.45.5.750

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  55 in total

1.  Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor.

Authors:  J H Henriksen; F Bendtsen; A L Gerbes; N J Christensen; H Ring-Larsen; T I Sørensen
Journal:  Hepatology       Date:  1992-11       Impact factor: 17.425

2.  Immunoradiometric assay of active renin versus determination of plasma renin activity in the clinical investigation of hypertension, congestive heart failure, and liver cirrhosis.

Authors:  P F Plouin; P Cudek; J F Arnal; T T Guyene; P Corvol
Journal:  Horm Res       Date:  1990

3.  Changes in plasma renin activity in cirrhosis: a reappraisal based on studies in 67 patients and "low-renin" cirrhosis.

Authors:  S P Wilkinson; I K Smith; R Williams
Journal:  Hypertension       Date:  1979 Mar-Apr       Impact factor: 10.190

Review 4.  Lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water.

Authors:  K Thomsen
Journal:  Nephron       Date:  1984       Impact factor: 2.847

5.  Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism.

Authors:  A Ganguly; J H Pratt; M H Weinberger; C E Grim; N S Fineberg
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958

6.  Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis.

Authors:  W Jiménez; A Martinez-Pardo; V Arroyo; J Bruix; A Rimola; J Gaya; F Rivera; J Rodés
Journal:  Hepatology       Date:  1985 Mar-Apr       Impact factor: 17.425

7.  Dopaminergic modulation of aldosterone responsiveness to angiotensin II with changes in sodium intake.

Authors:  M B Gordon; T J Moore; R G Dluhy; G H Williams
Journal:  J Clin Endocrinol Metab       Date:  1983-02       Impact factor: 5.958

8.  Dopamine inhibits the aldosterone response to upright posture.

Authors:  C D Malchoff; J Hughes; S Sen; S Jackson; R M Carey
Journal:  J Clin Endocrinol Metab       Date:  1986-07       Impact factor: 5.958

9.  Catecholamine responses to central volume expansion produced by head-out water immersion and saline infusion.

Authors:  G G Krishna; G M Danovitch; J R Sowers
Journal:  J Clin Endocrinol Metab       Date:  1983-05       Impact factor: 5.958

10.  Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation.

Authors:  M Bernardi; F Trevisani; C Santini; R De Palma; G Gasbarrini
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

View more
  6 in total

1.  Loss of tubuloglomerular feedback in decompensated liver cirrhosis: physiopathological implications.

Authors:  Giovanni Sansoè; Stefano Silvano; Giulio Mengozzi; Antonina Smedile; Giovanni Touscoz; Floriano Rosina; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

2.  Pathogenetic background for treatment of ascites and hepatorenal syndrome.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  Hepatol Int       Date:  2008-09-20       Impact factor: 6.047

3.  Renal tubular events following passage from the supine to the standing position in patients with compensated liver cirrhosis: loss of tubuloglomerular feedback.

Authors:  G Sansoè; A M Biava; S Silvano; A Ferrari; F Rosina; A Smedile; A Touscoz; L Bonardi; M Rizzetto
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

4.  Natriuretic and aquaretic effects of intravenously infused calcium in preascitic human cirrhosis: physiopathological and clinical implications.

Authors:  G Sansoè; F Wong
Journal:  Gut       Date:  2007-02-15       Impact factor: 23.059

5.  Sodium homeostasis with chronic sodium loading in preascitic cirrhosis.

Authors:  F Wong; P Liu; L Blendis
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

Review 6.  Management of cirrhotic ascites.

Authors:  Julie Steen Pedersen; Flemming Bendtsen; Søren Møller
Journal:  Ther Adv Chronic Dis       Date:  2015-05       Impact factor: 5.091

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.